ArgenTAG
ArgenTag Single-Cell RNA Library Kit for Oxford Nanopore and PacBio Long-Read Sequencing.
About ArgenTAG
Early Access program is now available. High resolution end-to-end solution in your bench for single-cell studies.
Recent Funding lists ArgenTAG under Health and bio. It went through IndieBio (IndieBio NY 04). It was founded by Leandro Ciappina, Pilar Bulacio and Elizabeth Tapia.
Funding rounds
- IndieBio NY 04
IIndieBio · batchSource: indiebio.co - X account created
- Website created
Founders and team
LC
Leandro Ciappina Co-founder & CEOsource: argentag.comPB
Pilar Bulacio Co-founder & CTOsource: argentag.comET
Elizabeth Tapia Co-founder & CSOsource: argentag.com
Investors
Similar Health and bio companies
HHexagon Bio$62M Series B+ · Oct 2026
BBioStack$9.5M Seed · Oct 2026HHeyVoli$500K Pre Seed · Oct 2026
VVitalls$1.5M Seed · Oct 2026
WWarp Sciences$215M Series A · Oct 2026
PPAM2L Biotechnologies$29.97M Series A · Oct 2026
Questions and sources
ArgenTAG: questions and answers
- Who invested in ArgenTAG?
- Investors on record for ArgenTAG: IndieBio.
- Who founded ArgenTAG?
- ArgenTAG was founded by Leandro Ciappina (Co-founder & CEO), Pilar Bulacio (Co-founder & CTO) and Elizabeth Tapia (Co-founder & CSO).
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/argentag (get a free API key).